Artificial Intelligence (AI), particularly generative AI, has been the buzzword promising massive transformation in the way Medical Affairs professionals do their jobs over the past year. Medical Affairs organizations, specifically the MSLs, Medical Writers, and Medical Researchers are experiencing a significant shift in their roles and responsibilities, but how exactly is the integration of AI technologies impacting their work? This article will explore the multiple ways that AI is impacting Medical Affairs and how organizations and individuals are leveraging this new technology to redesign their workflows and become more effective than ever before.
There is no limit to the potential use cases of AI in Medical Affairs. From the scientific literature review and summarization to Standard Response Letter automation to the creation of abstracts and manuscripts, generative AI has myriad applications in Medical Affairs teams. As the technology is still very new and constantly evolving, we’ve identified the 3 areas where AI has already been widely implemented to increase efficiencies around previously manual processes and free up MSLs and other team members to focus on more strategic activities as well as emerging use cases for generative AI in Medical Affairs.
Actionable Insight Generation
One of the most important ways AI is impacting Medical Affairs professionals is through enhanced data analysis and surfacing of actionable insights. AI algorithms can analyze vast amounts of patient data, clinical trials, publications, scientific literature, congress materials, internal private data sources, and CRM data to uncover invaluable insights that previously required hours of human curation to acquire. Insights have long been a vital output in the job of an MSL, but not always simple to truly quantify.
With generative AI, the arduous task of mining through notes and documents can now be handled by technology to generate accurate, actionable insights that MSLs can utilize to better understand disease patterns, treatment outcomes, the latest research, and industry trends in their therapeutic area. This enables them to engage healthcare providers with data-driven, up-to-date information, adding more value to their interactions with KOLs and ultimately improving patient care.
The medical field is constantly evolving, and staying informed of the latest research and industry trends is crucial for medical affairs professionals. AI-driven platforms can curate and deliver relevant content to MSLs, making it easier for them to stay informed about new treatments, clinical trials, and research findings. This ensures that medical affairs professionals are well-equipped to communicate the most current information to healthcare providers.
For medical writers and researchers, literature review is a critical part of their work. AI can significantly expedite this process by scanning through vast volumes of research papers and scientific publications and extracting relevant information. Medical affairs professionals can leverage AI to quickly gather evidence and stay updated with the latest findings in their respective fields.
Regulatory and Compliance
As with insight generation and literature review, generative AI’s impact on regulatory affairs cannot be overstated. AI has the ability to review documents, assessments, reports, and submissions to ensure compliance with the ever-evolving regulations in geographies around the globe. Medical writers and regulatory experts work closely with AI systems to maintain a high standard of quality assurance, minimizing errors and inconsistencies in documentation. What used to take months of research, curation, and content creation can now be accomplished in days.
Additionally, generative AI is being used to monitor and analyze adverse events related to medications. Medical Affairs professionals are integral in the pharmacovigilance process, and AI platforms have the ability to assist them in identifying potential safety concerns earlier. This enables them to quickly surface those potential issues internally and provide the correct guidance to healthcare providers more effectively than ever, thereby enhancing patient safety and regulatory compliance.
Emerging Uses of Generative AI
As generative AI continues to become more ingrained in the work of Medical Affairs organizations, the application of the technology will continue to expand. Content creation is one of the more intriguing use cases being employed by MSL and Medical Writing teams. Beyond the review, analysis, and summarization of publications, trials, literature, public data, and proprietary technical documents, AI platforms are being relied on to create the outputs for Medical Affairs teams.
From developing and modifying PowerPoint presentations on the fly to drafting abstracts and manuscripts to creating response letters and translating package inserts and informed consent documents, more and more Medical Affairs organizations are depending on their AI platforms to assist in creating content on their behalf. Is the output from artificial intelligence accurate enough to trust with such important work? Not yet. At least not fully. However, some platforms, such as Huma.AI, have been validated at over 97% accuracy. And technology continually gets smarter and smarter.
This is a very exciting time for Medical Affairs, as AI technology is rapidly changing the landscape and capabilities of the domain. Despite the many advantages, the integration of AI into Medical Affairs organizations is not without challenges. Ensuring data privacy, maintaining ethical standards, and eliminating the inaccuracies inherent in generative AI remain very serious concerns. While embracing this new technology into their work, Medical Affairs professionals need to properly monitor and correct the outputs of their generative AI partners to ensure accuracy and compliance.
One year ago, artificial intelligence was barely a consideration in our space. Today, it is a reality that is profoundly impacting Medical Affairs and every other department in Life Sciences companies. From improved data analysis and decision support to regulatory compliance and quality assurance to content creation and automation, generative AI is a transformative force in the industry. As exciting as this technological advancement may be, it is crucial that Medical Affairs professionals navigate the integration of AI with care, diligence, and a commitment to ethical considerations as they always have.
Huma.AI is a pioneering generative AI company with a platform designed specifically for Life Sciences. To request more information, please visit www.Huma.AI
About the author:
Lana Feng, PhD
Dr. Lana Feng is the co-founder and CEO of Huma.AI. She came from Novartis Oncology Business Unit where she established international partnerships for their late-stage targeted therapy programs. Dr. Feng joined Novartis through its acquisition of Genoptix. She built the BioPharma division at Genoptix, where she grew the business by forging alliances with pharmaceutical companies and providing biomarker and companion diagnostics development for targeted therapies. Prior to Genoptix, Dr. Feng held key positions at GeneOhm Sciences and Nanogen. Dr. Feng obtained her Ph.D. in Developmental Biology from Indiana University and did her post-doctoral training at UC, San Diego.